Ancillary tests in the diagnosis of liver and pancreatic neoplasms

Joseph Misdraji; Barbara A Centeno; Martha B Pitman

doi:10.1002/cncy.22009

Ancillary tests in the diagnosis of liver and pancreatic neoplasms

Cancer Cytopathol. 2018 Aug:126 Suppl 8:672-690. doi: 10.1002/cncy.22009.

Authors

Joseph Misdraji¹, Barbara A Centeno², Martha B Pitman¹

Affiliations

¹ Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
² Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, Florida.

PMID: 30156777
DOI: 10.1002/cncy.22009

Abstract

Ancillary tests in the diagnosis of liver and pancreatic neoplasms include a wide array of immunostains and molecular diagnostic tests, and the selection of tests is based on the differential diagnosis. This review discusses ancillary tests in the diagnosis of liver tumors, including benign and malignant primary tumors as well as metastatic tumors to the liver. In addition, ancillary tests for the diagnosis of both solid and cystic pancreatic neoplasms, including molecular tests in these lesions are also reviewed.

Keywords: ancillary; immunohistochemistry; liver; molecular diagnostic; neoplasm; pancreas.

Publication types

Review

MeSH terms

Cytodiagnosis / methods*
Diagnosis, Differential
Diagnostic Tests, Routine / methods*
Humans
Liver Neoplasms / diagnosis*
Pancreatic Neoplasms / diagnosis*